Mai 2013

Traditional & Novel Platforms for Immunogenicity Assessment of Biopharmaceutical Products

Algorithme Pharma provides immunogenicity services by developing and applying methods commonly required in safety and efficacy studies, such as PK/PD, bridging immunogenicity, drug tolerance and neutralization assays. We currently offer screening assays, antibody characterization and quasi-quantitative titers that describe Anti-Drug-Antibody (ADA) immune responses. These services are available on multiple platforms including the Mesoscale Discovery (MSD) Imager (ECL), Alpha-Lisa bead-based assays with luminescence or fluorescence detection, ELISA and our newest immunogenicity platform the SQI Diagnostics' SQiDlite^tm multiplexing system.

Click here to learn more »

Vince and Associates Clinical Research Joins the Altasciences Group

The Altasciences Group is proud to announce the addition of Vince and Associates Clinical Research to its team providing comprehensive Phase I/IIa clinical drug development capabilities. Both Vince and Associates Clinical Research and Algorithme Pharma operate with a common mission, to provide the best quality early stage clinical development services to an international customer base of pharmaceutical, biotechnology and generic companies with a focus on customer service.

Click here to learn more »

Innovative Solutions to Common Clinical & Bioanalytical Challanges

Our complimentary Science Exchange Symposium was successfully held on May 2, 2013 in the Cambridge, MA Biopharmaceutical center.

We would like thank all of those who joined us and made the event a success.